Royal Bank of Canada
AEHR icon

Royal Bank of Canada’s Aehr Test Systems AEHR Stock Holding History

Royal Bank of Canada’s Portfolio AEHR Stock Details AEHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.22M Buy
59,939
+7,968
+15% +$255K ﹤0.01% 3007
2025
Q4 		$1.05M Sell
51,971
-3,105
-6% -$75.1K ﹤0.01% 3614
2025
Q3 		$1.66M Buy
55,076
+31,770
+136% +$688K ﹤0.01% 3561
2025
Q2 		$301K Sell
23,306
-26,901
-54% -$256K ﹤0.01% 4849
2025
Q1 		$365K Buy
50,207
+36,364
+263% +$402K ﹤0.01% 4244
2024
Q4 		$231K Sell
13,843
-4,884
-26% -$65.1K ﹤0.01% 4693
2024
Q3 		$241K Buy
18,727
+5,779
+45% +$83.6K ﹤0.01% 4662
2024
Q2 		$145K Sell
12,948
-14,349
-53% -$167K ﹤0.01% 5006
2024
Q1 		$339K Sell
27,297
-41,853
-61% -$698K ﹤0.01% 4240
2023
Q4 		$1.83M Buy
69,150
+20,056
+41% +$585K ﹤0.01% 3147
2023
Q3 		$2.24M Buy
49,094
+3,663
+8% +$170K ﹤0.01% 2751
2023
Q2 		$1.87M Buy
45,431
+477
+1% +$15.7K ﹤0.01% 2892
2023
Q1 		$1.39M Buy
44,954
+44,883
+63,215% +$1.45M ﹤0.01% 3086
2022
Q4 		$1K Sell
71
-936
-93% -$20K ﹤0.01% 6993
2022
Q3 		$14K Sell
1,007
-52,618
-98% -$708K ﹤0.01% 6271
2022
Q2 		$403K Buy
53,625
+13,353
+33% +$111K ﹤0.01% 4261
2022
Q1 		$409K Buy
40,272
+20,822
+107% +$266K ﹤0.01% 4429
2021
Q4 		$470K Buy
19,450
+19,380
+27,686% +$379K ﹤0.01% 4523
2021
Q3 		$1K Buy
+70
New +$503 ﹤0.01% 7442
2020
Q4 		– Sell
-261
Closed – – 7035
2020
Q3 		$0 Sell
261
-282
-52% -$523 ﹤0.01% 6569
2020
Q2 		$1K Buy
543
+12
+2% +$21 ﹤0.01% 6370
2020
Q1 		$1K Buy
531
+262
+97% +$505 ﹤0.01% 6390
2019
Q4 		$1K Sell
269
-53
-16% -$99 ﹤0.01% 6620
2019
Q3 		$1K Buy
+322
New +$461 ﹤0.01% 6380
2018
Q4 		– Sell
-38
Closed – – 6694
2018
Q3 		$0 Buy
+38
New +$94 ﹤0.01% 6675
2017
Q4 		– Sell
-17
Closed – – 6495
2017
Q3 		$0 Buy
+17
New +$61 ﹤0.01% 6671

Other funds holding AEHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royal Bank of Canada's AEHR Position: Q1 2026 in Review

Royal Bank of Canada increased its Aehr Test Systems (AEHR) stake by 15% in Q1 2026, buying an estimated $255K and bringing the position to 59,939 shares worth $2.22M. The position accounts for ﹤0.01% of the portfolio, ranked #3007.

Royal Bank of Canada first reported a position in AEHR in Q3 2017 and has held it in 26 quarters since. The position peaked at $2.24M in Q3 2023. 191 funds tracked by Wall St. Rank hold AEHR as of Q1 2026.

  • Royal Bank of Canada held 59,939 shares of Aehr Test Systems worth $2.22M as of Q1 2026.
  • Royal Bank of Canada bought 7,968 Aehr Test Systems shares in Q1 2026, an estimated $255K.
  • Aehr Test Systems made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #3007 holding.
  • Royal Bank of Canada first reported a position in Aehr Test Systems in Q3 2017 and has held it in 26 quarters since.
  • Royal Bank of Canada's Aehr Test Systems position peaked at $2.24M in Q3 2023.
  • 191 funds tracked by Wall St. Rank held Aehr Test Systems as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.